Precision oncology detects small tumors through circulating tumor cells and DNA methylation, then uses minimally invasive treatments like cryoablation to eradicate them without surgery. For advanced cancer, genetic profiling identifies driver mutations, enabling immune cells trained as "sniper" attackers that recognize and remember tumor antigens for lasting remission.
Think of a small tumor. We run circulating tumor cells, C.T. free DNA methylation. We know it's localized to one area. We don't even need to do surgery. We can freeze it. It's called cryoablation. Or we can chemoembolize it, Go right into the tumor with a catheter as small as a hair, Cut the blood supply, deliver the chemotherapy, shut it off. It's done with minimal to no collateral damage. And now the patient is in remission, and we can continue to monitor that. But once we know that cancer spread, now we use the same precision targeting to help the patient. We run DNA so we can see the exact genetic mutations to that cancer RNA transcriptome. So we know what are the drivers to the cancer. So we know all the roads, all the villages, all the houses that king tumor is trying to attack and shut them down. And then we build immune spatial biology. So now we build the immune system to go in with targeted snipers and take the cancer out. Teach all the villagers where the king Tumor is and any of his men so they can do the rest of taking that out and have the memory of that. So to do it over time.
